Marie-Kathrin Breyer

Prof. Dr. Marie-Kathrin Breyer


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CLCharmaine Jie Min Lim
Charmaine Jie Min Lim
CGChristoph Gross
Christoph Gross
MBMarie-Kathrin Breyer
Marie-Kathrin Breyer
RBRobab Breyer-Kohansal
Robab Breyer-Kohansal
EWEmiel Wouters
Emiel Wouters
SHSylvia Hartl
Sylvia Hartl
Background: In patients with airflow obstruction, the levels of biomarkers of Type-2 (T2) inflammation serve to predict the effectiveness of inhaled corticosteroid and biological therapies. Elevated biomarkers of T2 inflammation, including fractional exhaled nitric oxide (FeNO, ≥20 ppb) and blood eosinophil counts (BEC, ≥300 cells/µL), were investigated in a population-based cohort of the Austrian LEAD study. Methods: A total of 4976 individuals (aged 18–82 years) were categorised into four groups based on their FeNO and BEC levels: normal with FeNO < 20 ppb and BEC < 300 cells/µL (n = 2634); FeNO ≥ 20 ppb only (n = 1623); BEC ≥ 300 cells/µL only (n = 340); and FeNO ≥ 20 ppb and BEC ≥ 300 cells/µL (n = 379). Results: In age- and sex-adjusted regression models, individuals with elevated BEC only were most associated with chronic cough and sputum production (odds ratios [95% CI]: 1.22 [0.78, 1.84] and 1.37 [1.13, 2.62], respectively), whilst individuals with both elevated T2 biomarkers were most associated with wheezing, dyspnoea and asthma (odds ratios [95% CI]: 2.27 [1.56, 3.26], 1.32 [0.64, 2.50] and 3.63 [2.69, 4.88] respectively). Elevated levels of both FeNO and BEC presented an additive effect in extrapulmonary conditions, particularly in allergy, eczema and rhino conjunctivitis (odds ratios [95% CI]: 2.30 [1.84, 2.88], 1.37 [1.03, 1.81] and 2.95 [2.34, 3.70], respectively). Conclusions: T2 inflammation marked by elevated levels of FeNO and/or BEC is not only associated with respiratory conditions but also extends to extrapulmonary characteristics, with an additive effect.

28 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
OHOliver Helk
Oliver Helk
CLCharmaine Jie Min Lim
Charmaine Jie Min Lim
MMMatthäus Metz
Matthäus Metz
EWEmiel Wouters
Emiel Wouters
RBRobab Breyer-Kohansal
Robab Breyer-Kohansal
MBMarie-Kathrin Breyer
Marie-Kathrin Breyer
Background/Objectives: Serum creatinine (SCr)-based estimates of glomerular filtration rate (eGFRSCr) are influenced by muscle mass. This study investigated whether normalizing SCr to dual-energy X-ray absorptiometry (DEXA)-derived lean mass index (LMI) alters associations with cardiometabolic phenotypes. Methods: We analyzed 11,141 adults (mean age 46.0 ± 17.2 years) from the Austrian LEAD (Lung, hEart, sociAl, boDy) cohort. SCr was normalized to sex- and age-specific LMI reference values to calculate LMI-adjusted eGFR (eGFRLMISCr) within individuals. Associations with prevalent cardiometabolic conditions were compared using age- and sex-adjusted logistic regression with paired bootstrap resampling. Annualized eGFR change was compared in 7487 participants with complete follow-up measurements. Results: The estimates were closely correlated (R2 = 0.897), but LMI adjustment changed GFR-category assignment in both directions. Higher eGFRLMISCr was positively associated with prevalent dyslipidemia, hypertension, pre-diabetes, diabetes, metabolic syndrome and obesity. Differences in annualized change depended on age and sex, with lower LMI-adjusted slopes in women, particularly at younger ages, and higher slopes in men. Conclusion: LMI adjustment influences eGFR slopes in a sex- and age-specific manner and changes both filtration function category assignment and associations with cardiometabolic phenotypes. As these associations may partly reflect the direct incorporation of body composition into the estimate, our findings will require validation against measured GFR or an independent filtration marker.

17 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
OHOliver Helk
Oliver Helk
CLCharmaine Jie Min Lim
Charmaine Jie Min Lim
MMMatthäus Metz
Matthäus Metz
EWEmiel Wouters
Emiel Wouters
RBRobab Breyer-Kohansal
Robab Breyer-Kohansal
MBMarie-Kathrin Breyer
Marie-Kathrin Breyer
Background/Objectives The accurate estimation of glomerular filtration rate (GFR) is essential for assessing trends in the prevalence (CKD), yet standard serum creatinine (SCr)-based estimates (eGFRSCr) are limited by individual variations in muscle mass. While demographic surrogates like age and sex are typically used to account for these variations, they often lead to eGFR misclassification in individuals. This study investi-gated whether normalizing SCr to Dual-energy X-ray absorptiometry (DEXA)-derived Lean Mass Index (LMI) improves the association with cardiometabolic risk. Methods We analyzed data from 11,143 adults (mean age 46.0 ± 17.2 years) in the Austrian LEAD (Lung, hEart, sociAl, boDy) cohort. Individual SCr concentrations were normalized to sex- and age-specific LMI reference values to calculate LMI-adjusted eGFR (eGFRLMISCr). The strength of associations between eGFRSCr and eGFRLMISCr with cardiometabolic risk factors (dyslipidemia, hypertension, pre-diabetes/diabetes, and metabolic syndrome) was compared using age- and sex-adjusted logistic regression with bootstrap resampling. Results While eGFRSCr and eGFRLMISCr were highly correlated (R2 = 0.897), LMI adjust-ment led to significant reclassification between CKD stages G1, G2, and G3a. eGFRLMISCr demonstrated significantly stronger associations with dyslipidemia, arterial hyperten-sion, pre-diabetes/diabetes, and metabolic syndrome compared to standard eGFRSCr. Longitudinal analysis showed that LMI adjustment stabilizes eGFR change estimates, particularly in younger men. Conclusion Adjusting serum creatinine for LMI signifi-cantly enhances the epidemiological utility of GFR estimation. GFRLMISCr improves car-diometabolic risk stratification, potentially offering a valuable method to "salvage" the utility and comparability of eGFRSCr in historic cohorts in early-stage filtration impair-ment in settings where DEXA but not Cystatin C is available.